A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe Disease
Trial details
- Registry ID
- NCT07908381
- Drugs studied
- zelicapavir
TrialRedline tracks 8 clinical trials sponsored by Enanta Pharmaceuticals, Inc: 1 Phase 2 / 3, 7 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe DiseaseNCT07908381 | zelicapavir | Recruiting | 2029-07Estimated |
Names as written in the registry records.
NCT05568706 · Enanta Pharmaceuticals, Inc
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Time to resolution of RSV Lower Respiratory Tract Disease (LRTD) symptoms. After: Measure: Time to Resolution of RSV Lower Respiratory Tract Disease (LRTD) Symptoms Measure: Time to Complete Resolution of LRTD Symptoms for the mITT Population Measure: Time to Complete Resolution of LRTD Symptoms for the HR3 Population.
Before: 186 participants (actual). After: 187 participants (actual).
NCT07482657 · Enanta Pharmaceuticals, Inc
Before: Not yet recruiting. After: Recruiting.